May 2019 Vol. 11 Issue 5

Book Review: Natural Eye Care

by Jen Green, ND, FABNO
Dr Jen Green reviews a new “highly efficient” clinical resource for treating eye conditions in an integrative fashion.

Melatonin to Prevent ICU Delirium

by Kelsey Asplin, ND
Delirium is a common complication among patients in the intensive care unit, but treatment options are limited and pose additional risks. Could melatonin, a simple and nontoxic intervention, be an effective therapy for this condition?

Understanding the Ethical Pitfalls Associated with Content Marketing

by Natural Medicine Journal
Using content to connect with potential patients and grow a medical practice has become increasingly popular. Most practice owners are using some form of content to promote their business including a website, blogs, podcasts, social media posts, and/or email campaigns. In this podcast, the ethical ramifications of content marketing are explored with naturopathic physician and medical writer, Sarah Cook, ND.

Diet and Risk of Prostate Cancer Recurrence

by Jacob Schor, ND, FABNO
This peer-reviewed paper presents a comprehensive review of the latest evidence to support specific dietary recommendations for men with prostate cancer. Data suggests there is no one-size-fits-all solution; recommendations for prevention may differ from those for reducing risk of progression or recurrence, and there may even be inter-individual variation.

Childhood Residential Green Space Exposure Predicts Future Risk of Psychiatric Diagnosis

by Kurt Beil, ND, LAc, MPH
Exposure to green space has been shown to improve mental health in both children and adults. A large study involving nearly 1 million people is the first to show a relationship between green space exposure during childhood and risk of mental illness in adulthood.

The Importance of Beta Cell Preservation in Newly Diagnosed Type 1 Diabetes

by Jody Stanislaw, ND, CDE
A retrospective study finds that children with type 1 diabetes who experience partial remission (“honeymoon” phase) have lower low-density cholesterol levels up to 5 years post-diagnosis, prompting the question: could interventions to protect islet cells prevent long-term complications?